Literature DB >> 23750840

Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies.

E Ong, A Viaccoz, F Ducray, M Pérol, G Cavillon, V Rogemond, J Honnorat, P Petiot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23750840     DOI： 10.1111/ene.12164

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  7 in total

1.  Morvan's syndrome treated successfully with rituximab and lacosamide.

Authors:  Olafur Sveinsson; Faiez Al Nimer; Fredrik Piehl
Journal:  BMJ Case Rep       Date:  2019-02-13

2.  Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report.

Authors:  Edvina Galié; Rosaria Renna; Domenico Plantone; Andrea Pace; Mirella Marino; Bruno Jandolo; Tatiana Koudriavtseva
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

3.  Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.

Authors:  Kristina R Patterson; Josep Dalmau; Eric Lancaster
Journal:  Ann Neurol       Date:  2018-01-10       Impact factor: 10.422

Review 4.  Current Treatment Options for Peripheral Nerve Hyperexcitability Syndromes.

Authors:  Cheran Elangovan; Adeolu Morawo; Aiesha Ahmed
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.972

5.  Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies.

Authors:  Kurt-Wolfram Sühs; Thomas Skripuletz; Refik Pul; Sascha Alvermann; Philipp Schwenkenbecher; Martin Stangel; Kirsten Müller-Vahl
Journal:  Mol Brain       Date:  2015-10-13       Impact factor: 4.041

6.  Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody.

Authors:  Ying Hou; Chao Zhang; Xiaolin Yu; Wenqing Wang; Dong Zhang; Yunfei Bai; Chuanzhu Yan; Lin Ma; Anning Li; Jian Ji; Lili Cao; Qinzhou Wang
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

Review 7.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.